Current Status of Pain Treatment: Medical Needs, Basic Research, and Exploration of New Therapeutics
★What are the actual drug selection and treatment processes for chronic pain management? ★Profile of the desired medication, expected cascade, and promising future analgesic cascades.
【Lecturers】 Professor Shinsuke Hamaguchi, Department of Anesthesiology, Dokkyo Medical University Dr. Kenji Miki, Deputy Chief of Orthopedics, Amagasaki Central Hospital, Specialist in Pain Management, Osaka University Medical Hospital 【Venue】Industrial Promotion Hall, Conference Room 1【Kanagawa, Kawasaki Station】 【Date and Time】December 13, 2010 (Monday) 11:00-15:00 【Capacity】30 people *Registration will close once full. Please apply early. 【Participation Fee】45,150 yen per person (including tax, textbook fee, and tea cost) New members applying for the first time by December 3 will receive an early bird discount price of 39,900 yen. ◆For two applicants from the same organization, the fee is 69,300 yen. For more details or to consider applying, please use the URL below ▼ http://ec.techzone.jp/products/detail.php?product_id=1270
![002426[1].jpg](https://image.mono.ipros.com/public/product/image/cd2/2000000857/IPROS8832171601207430874.jpg?w=280&h=280)
Inquire About This Product
basic information
**Lecture Summary** In recent years, the treatment of chronic pain has been undergoing significant changes due to the emergence of new medications. This lecture will explain the selection of drugs and the treatment process, summarizing both old and new analgesics used in the pharmacotherapy of chronic pain. **Lecture Summary** The treatment of musculoskeletal pain disorders (mostly chronic pain patients) in orthopedic practice has long relied solely on the administration of anti-inflammatory analgesics, including topical patches. In contrast, the recently introduced neuropathic pain medications and opioids are not just symptomatic treatments but are capable of aiming for curative therapy. This presentation will provide an outlook on future treatments for musculoskeletal pain disorders, taking into account not only domestic information but also international data and clinical trial experiences.
Price information
New members who apply for the first time by December 3rd will receive an early bird discount price of 39,900 yen.
Price range
P2
Delivery Time
P2
※Scheduled delivery of the course ticket.
Applications/Examples of results
Part 1: Case Studies on Chronic Pain - Recent Drug Selection and Treatment Processes, and Future Required Medications 【11:00-12:30】 1. The Importance of Chronic Pain Treatment 2. Practical Aspects of Pharmacotherapy - Adjuvant Analgesics 3. Pharmacotherapy - Actual Drug Selection and Treatment Processes for Chronic Pain 4. Opioid Analgesics - Usage and Issues of Oral Opioid Analgesics - Current Use of Fentanyl Patches in Chronic Pain Patients at Our Hospital 5. Experience with Drugs Available Since 2010 and Future Challenges 【Q&A and Business Card Exchange】 Part 2: Trends in Promising Analgesic Cascades and the Current Status of Chronic Pain Diseases and Fibromyalgia in Japan and Abroad from an Orthopedic Perspective 【13:30-15:00】 1. Number of Musculoskeletal Pain Patients The number of musculoskeletal pain patients is a large market, exceeding 10 million. 2. What are Musculoskeletal Pain Diseases? 3. Mechanisms of Pain Originating from Various Joint Pains 4. New Diagnostic Criteria for Fibromyalgia 5. Treatment of Joint Pain and Pain Relief in Orthopedics 6. Opioid Treatment for Chronic Musculoskeletal Pain 7. Expectations for Pain Treatment Medications, Desired Drug Profiles, Anticipated Cascades, and Promising Analgesic Cascades
Company information
Our company has developed its business from "seminar planning" to various forms such as "lecturer dispatch," "publishing planning," "technical consultant dispatch," "trend research," "business matching," and "business development consulting," in order to support clients in a wide range of fields including chemistry, electronics, automotive, energy, medical devices, food, and building materials. By doing so, we have advanced our company and opened up new markets. AndTech promises to continue listening to our clients' voices, entering the business areas and markets they desire, and to remain a company that is loved by our clients, as we share their challenges, think together, and forge new paths.
![[Helpfeel Case Study] Daiichi Sankyo Healthcare Direct](https://image.mono.ipros.com/public/product/image/2126786/IPROS12718470352548825688.png?w=280&h=280)
![[Market Report] Global Nucleic Acid Medicine Market](https://image.mono.ipros.com/public/product/image/d58/2001090390/IPROS17046193649975477841.jpeg?w=280&h=280)
![[Research Material] Global Market for Treatment of Head Lice Infestation](https://image.mono.ipros.com/public/product/image/609/2001467525/IPROS50826046643529000810.jpeg?w=280&h=280)
![Basic Seminar for Obtaining the China CCC Mark [December 20, Tokyo]](https://image.mono.ipros.com/public/product/image/bf6/2000122724/IPROS8595059909811374036.png?w=280&h=280)
